In the present study, we observed that pioglitazone can reduce intraneuronal Aβ levels via inhibition of PPARγ phosphorylation, which functions via inhibition of CDK5 expression, thereby upregulating the expression of IDE and downregulating the expression of BACE1 in a neuronal model of AD. The gene discussed is IDE; the disease is Alzheimer disease.